Long term is one year and a day and taxed at 20%. Anything
Long term is one year and a day and taxed at 20%. Anything less than that is ordinary income and taxed at your highest tax rate.
As for which shares sell first, just specify it when you put up your ASKS. You can specify last shares purchased or first shares purchased, the ones you spent the most on or the least on, etc. - but make sure you specify AT THE TIME YOU PLACE YOUR ASKS based on your own personal goals and situation.
For instance, in the case of my new bride, she will sell the most recent shares purchased first (those purchased in July), and her first purchases.....made in February.....last. In that way, there is a very good chance that she will take advantage of the year and a day rule and only pay 20% taxes on a good portion of her shares.
One last thing: There is an SEC 2 year rule regarding PP and Baltia's filing of their 10-Q. If Baltia files their 10-Q late, then any shares purchased via PP that are less than 2 years old cannot be sold until apparently the next quarterly filing is done on a timely basis......and of course if that one is late, then the next filing, etc.
LOL.........I wonder if Baltia has been DELIBERATELY filing late to further restrict the number of shares available in the float?.............................................
Baltia Air Lines Inc (BLTA) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
A Double Decade Celebration of Dream and Dedication The Miracle League of the Triangle sure knows how to throw a party—for them, it's not just a gala; it's a testament to two decades of turning dreams into reality. On October 13th, over 300 guests gathered at the Angus Barn Pavilion in Cary, NC, proving that passion for inclusive baseball is just as alive as it was 20...
Continue Reading
Pedaling for Purpose: A Journey That Sparked a Movement What started as a lone journey across America's roads has turned into a celebrated movement to honor those who often go unnoticed. Back in 2009, Shawn Anderson embarked on an unusual journey. Armed only with a bicycle and determination, he pedaled from San Francisco to Boston—over 4,000 miles in just 90 days. It...
Continue Reading
Fidelis Care Steps Up Workforce Engagement Fidelis Care's latest move introduces a fresh shot at tackling two birds with one stone—economic and health stability for Medicaid members. The Workforce Pathways to Health and Economic Mobility grants present up to $120,000 in support for New Yorkers, an attempt aimed squarely at reducing the vicious cycle that traps many in...
Continue Reading
Mixing Hockey and Hamburgers: The Peltz Way You'd think a guy like Nelson Peltz wouldn't be juggling hockey sticks and hamburgers at the same time, but here we are. The man, a mogul of sorts with Trian Fund Management, is hopping onto a board seat with a New York hockey company and, oh, by the way, throwing a non-binding $7.35-a-share cash proposal to snatch up Wendy's, a...
Continue Reading
Weathering the Storm: A New Chapter for Jamaica It's been nearly a year since Hurricane Melissa hit, and Jamaica is proving that it won't be pushed around by nature's whims. The island's tourism industry, once battered, is now showing remarkable resilience. With hotels and villas reopening and shaking off the dust, it's safe to say Jamaica is back on its feet, and it's...
Continue Reading
Decades of Trust in Cancer Care Virginia Cancer Specialists isn't just another name in the sea of healthcare providers. That pride they're feeling? Well, they've got every right to it. Just slapped their physicians' names all over the latest Washingtonian's Top Doctors list for 2026. And this isn’t some under-the-table handshake deal. No, this list is shaped by peer...
Continue Reading
There's a fresh breeze blowing through the dusty corridors of healthcare, shaking things up for the better. You see, Genefluence, the brainchild of Professor Chris Toumazou, isn't just throwing a bunch of tech jargon around—it's setting the stage for a much-needed shake-up in how we handle urinary tract infections (UTIs) and, believe me, it couldn’t have come sooner....
Continue Reading
The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...
Continue Reading
From Humble Beginnings to High Achiever Alright, let's touch base on Canada's tech landscape for a moment. Infoya's leap into Deloitte's 2026 Technology Fast 50 isn't just a pat on the back—it's a flashing neon sign of what raw ambition mixed with a pinch of AI can cook up for you. They've banked a whopping 665% revenue growth from 2022 to 2025. Not bad for a company...
Continue Reading
Wine Industry Shifts Gears Well, here's a twist that might just shake up the wine racks. C. Mondavi & Family, from the historic Charles Krug estate, is aligning with Missing Thorn—a name gaining traction in the non-alcoholic wine scene. It’s a move that not only raises eyebrows but could also expand your wine-tasting options come your next sober night out. So what...
Continue Reading
Top 5 Most Recently Viewed Articles
The American Institutes for Research (AIR) has launched a hefty initiative aimed at elevating care quality for those on Medicare and Medicaid grappling with serious mental health issues and substance use disorders. This venture solidifies AIR's role in advocating better health outcomes among these vulnerable groups. AIR's Heavy Hit: $73 Million from CMS In a noteworthy...
Continue Reading
SimSpace Strengthens Leadership with Peter Lee Appointment SimSpace, a leader in the realm of cyber readiness and security optimization, has announced a significant new addition to its Board of Directors: Peter Lee. Recognized for his vast experience in scaling technology companies and a strong background in private equity, Peter's appointment comes at a crucial time as...
Continue Reading
Avocado Oil Market Dynamics and Growth Trends Burlingame, CA – Recent insights reveal that the avocado oil market is on a remarkable growth trajectory. According to comprehensive studies, the market was valued at USD 705.3 million and is set to exceed USD 1,054.2 million by 2032, reflecting a compound annual growth rate (CAGR) of 5.9% during this period. This increase...
Continue Reading
China’s stock market saw its biggest jump since 2008 when the government rolled out a hefty $114 billion in stimulus. Traders were buzzing about interest rate cuts too, hinting at a genuine attempt to kickstart economic momentum. But let’s not kid ourselves—this is no magic bullet. The backdrop of geopolitical tensions and an ongoing property crisis loomed large...
Continue Reading
Venture Global, Inc. Class Action Update Venture Global, Inc. has recently come into the spotlight as a result of a securities class action lawsuit filed on behalf of its investors. This lawsuit, initiated in the Southern District of New York, claims that the company made several misleading statements regarding its initial public offering (IPO) documents. Investors who...
Continue Reading